FDA awards grant for phase 1 clinical trial of experimental AML/MDS treatment

  • Post author:
  • Post category:uncategorized

Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)-;two related blood diseases that disproportionally strike older adults-;are notoriously difficult to treat and associated with high relapse rates.